Kalkine Media

Edwards Lifesciences Leads Healthcare Stocks in S&P 500

Explore Edwards Lifesciences (NYSE:EW) leading innovations in heart care and its impact on S&P 500 healthcare stocks.

Edwards Lifesciences slips as Oppenheimer downgrades on upcoming data

Edwards Lifesciences (EW) stock slips as Oppenheimer downgrades the company to Perform from Outperform citing concerns over two upcoming trial readouts. Read more here.
Bangkok Post on MSN

Edwards Lifesciences Launches Groundbreaking Transcatheter Heart Valve Technology in Thailand

New innovation marks a major step toward reducing Thailand's healthcare burden as 80% of cardiovascular diseases are preventable.1,2 Edwards Lifesciences (NYSE: EW), the global leader in structural ...
nottinghamworld.com on MSN

Spire Nottingham Hospital pioneers groundbreaking open-heart surgery with innovative valve replacement

Spire Nottingham Hospital has reached a historic milestone in cardiac surgery, becoming the first private hospital in the ...

Abbott to Report Q3 Earnings: Medical Devices Arm in Focus

Detailed price information for Abbott Laboratories (ABT-N) from The Globe and Mail including charting and trades.

Edwards Lifesciences (EW): Assessing Valuation Following Recent Share Price Decline

Edwards Lifesciences (EW) has seen its stock trend lower over the past month, down about 6%. Investors are keeping an eye on ...
GamesRadar+

Everything we know about Valve Deckard, the long-awaited sequel to Valve's Index VR headset

Depending on who you ask, the Valve Index is still one of, if not the greatest, VR headset ever made. For many gamers, it was the first virtual reality device that was worth buying, which gave them ...